Frank Verwiel's most recent trade in Intellia Therapeutics Inc was a trade of 11,450 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,450 | 11,450 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 8,000 | 25,948 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 17 Jun 2024 | 1,505 | 17,948 (0%) | 0% | 25 | 37,625 | Common Stock |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 11,515 | 11,515 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 7,737 | 19,453 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,473 | 6,473 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,425 | 11,716 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 7,291 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 3,382 | 3,382 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Frank Verwiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 2,094 | 2,094 (0%) | 0% | 0 | Common Stock |